# Umbilical Cord Mesenchymal Stem Cells Therapy for Diabetic Nephropathy

> **NCT04125329** · EARLY_PHASE1 · UNKNOWN · sponsor: **Yan'an Affiliated Hospital of Kunming Medical University** · enrollment: 15 (estimated)

## Conditions studied

- Mesenchymal Stem Cells
- Diabetic Nephropathy

## Interventions

- **DRUG:** Human umbilical cord mesenchymal stem cells

## Key facts

- **NCT ID:** NCT04125329
- **Lead sponsor:** Yan'an Affiliated Hospital of Kunming Medical University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-04-01
- **Primary completion:** 2024-09-01
- **Final completion:** 2024-09-01
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2021-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04125329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04125329, "Umbilical Cord Mesenchymal Stem Cells Therapy for Diabetic Nephropathy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04125329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*